-
It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Nexium Delayed-Release Capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP.
-
The company in a release stated that the DGCI has granted extended indication approval for Dapagliflozin in the treatment of heart failure in adults
-
Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk of patients dying by 51 per cent
-
CDSCO has approved AstraZeneca Pharma India's liver cancer drug Tremelimumab Concentrate to be administered intravenously
-
New Delhi: The increase in monkeypox cases has led to a rash of social media posts, many claiming the chimpanzee adenovirus vector used in AstraZeneca’s Covid vaccine is behind the outbreak and some suggesting the infection is basically shingles and a “well-known” side effect of the jab. Experts that PTI spoke to said both claims, […]
-
Washington: The efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot to increase their protection, Moderna CEO Stephane Bancel has said. According to Bancel, people who received their boosters last year will likely have enough protection to get them through the winter, when new infections surge as […]
-
Hyderabad: The immunity against Covid gained by individuals who were administered with two doses of the AstraZeneca vaccine (Covishield) is waning quickly, raising fears among public health officials here. They say that a combination of the unvaccinated population and those who were vaccinated immediately after the launch of Covid vaccines might trigger a fresh surge […]
-
Hyderabad: The Biden administration has announced revised international air travel rules for those flying to the United States, with the rules to come into effect from November 8. According to a communiqué from the White House, details of which are available on www.cdc.gov/ and https://travel.state.gov/content/travel.html as well, starting November 8, all foreign national air travellers […]
-
Bengaluru: AstraZeneca India on Tuesday partnered with health-tech startup Tricog to roll out a programme called ‘Project Heartbeat’, focused on early and accurate diagnosis of heart attack patients, to reduce mortality rates. The project addresses the unmet need for early diagnosis and intervention for patients with suspected heart attack by enabling cloud-based artificial intelligence (AI) […]
-
Planning at the district level in India will be crucial in the journey ahead
-
It is argued that such a mixed regimen will help overcome the challenges of the shortfall of certain vaccines and remove hesitancy, especially in settings where multiple Covid-19 vaccines are being used
-
The statement comes following the UK Prime Minister Boris Johnson’s announcement that people wanting to enter nightclubs and venues holding large crowds will need to show proof of vaccination.
-
With the delta variant, a study by British researchers found people were well protected when they got both doses of either the AstraZeneca or Pfizer-BioNTech vaccines.
-
The booster shot, named AZD2816, will be administered to individuals who have previously been fully vaccinated with two doses of AstraZeneca vaccine/Vaxzervia or an mRNA vaccine, at least three months after their last injection.
-
Scores of NRIs who had gone to India had taken Covishield as it continues to be the mainstay of India’s Covid-19 vaccination drive
-
Show cause notices sent to 64 hospitals across Telangana on complaints related to Covid treatment
-
The firm did not want the videos to be branded nor did they reveal the name of the client behind the project.
-
As of Saturday, over 26.6 million vaccine doses had been administered throughout Italy.
-
The 12-16 weeks gap for Covishield will not only boos its efficacy but also help vaccine administration effectively and provide breathing space to the governments for improving supply
-
According to the WHO's statistics, as of Wednesday, at least 2.6 million people have died of Covid-19 worldwide.